However, some cancer cells that express high levels of glutamine synthetase (GS), the enzyme responsible for de novo glutamine production, have increased glutamine-dependent anabolic processes and are more resistant to glutamine deprivation than cells with low GS expression [10,11,12,13,14,15]. The gene discussed is GLUL; the disease is cancer.